HOME › Research Insight › New innovative and cost effective product lauches are adopted as the key strategy by the leading firms

New innovative and cost effective product lauches are adopted as the key strategy by the leading firms

The key priority for the present resin producers is to bring about resins with better binding properties and lower costs. Leading firms such as GE Life Sciences, Bio-Rad, Tosoh Corporation, and Millipore focus on producing lower priced resins with high productivity, which is what will help companies garner a competitive edge. Presently, affinity chromatography resins such as protein A based resins are extremely expensive, however, with the expiry of a number of patents could reduce the price in future.

The key priority for the present resin producers is to bring about resins with better binding properties and lower costs. Leading firms such as GE Life Sciences, Bio-Rad, Tosoh Corporation, and Millipore focus on producing lower priced resins with high productivity, which is what will help companies garner a competitive edge. Presently, affinity chromatography resins such as protein A based resins are extremely expensive, however, with the expiry of a number of patents could reduce the price in future. According to industry experts, presently, the average price of affinity chromatography resins could come down to $8000 to $9500 per liter in the next five years from $12000 to $15000 per liter. This is primarily due to increasing research efforts towards the production of low priced resins and expiring patents.

New product launch was the preferred strategy adopted by the top chromatography resin manufacturers during the last four years. All the leading manufacturers are focusing on launching resin with high productivity and more specific binding properties. GE Healthcare, Bio-Rad, Tosoh Corp. and Merck Millipore announced a number of new launched during 2010-2013. The figure below shows the strategies adopted by the top 13 players in chromatography resin market from 2010 till 2013